Diffusion Weighted Imaging on a 3 Tesla Magnetic Resonance Scanner as a Diagnostic Tool in Early Detection of Prostate Cancer

Diffusion Weighted Imaging on a 3 Tesla Magnetic Resonance Scanner as a Diagnostic Tool in Early Detection of Prostate Cancer

Introduction: Multiparametric Magnetic Resonance Imaging (MRI) of prostate including Diffusion Weighted Imaging (DWI) is greatly evolving as a diagnostic tool in prostate cancer. Incidence of prostate cancer in India is on rise with most of the cases been diagnosed in late stages. In this scenar...

Full description

Bibliographic Details
Main Authors:	Ruchira Das, Archana Singh, Sudipta Saha, Shubham Saha, Dilip Kumar Pal, Utpalendu Das, Madan Karmakar
Format:	Article
Language:	English
Published:	JCDR Research and Publications Pvt. Ltd. 2021-07-01
Series:	International Journal of Anatomy Radiology and Surgery
Subjects:	biopsy diagnostic imaging magnetic resonance imaging prostate carcinoma
Online Access:	http://www.ijars.net/articles/PDF/2668/48949_CE[Ra1]_F(SHU)_PF1[AKA-IK]_PFA_NC_PN(KM).pdf

Similar Items

Usefulness of Bi-Parametric Magnetic Resonance Imaging with b=1,800 s/mm2 Diffusion-Weighted Imaging for Diagnosing Clinically Significant Prostate Cancer
by: Seung Soo Lee, et al.
Published: (2020-07-01)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
by: Thais Caldara Mussi, et al.

Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner
by: Abdallah Sharqawi, et al.
Published: (2023-04-01)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
by: Dominic James Gavin, et al.
Published: (2020-07-01)

Role of exponential apparent diffusion coefficient in characterizing breast lesions by 3.0 Tesla diffusion-weighted magnetic resonance imaging
by: Shweta Kothari, et al.
Published: (2017-04-01)

Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer
by: Rohit Kaushal, et al.
Published: (2019-05-01)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Francesco Porpiglia, et al.
Published: (2015-02-01)

Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
by: John Shung-Lai Leung, et al.
Published: (2024-01-01)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
by: Nicolette G. Alkema, et al.
Published: (2022-10-01)

Office-based Magnetic Resonance Imaging–guided Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Real-world Clinical Utility Study
by: Lars Boesen, et al.
Published: (2024-01-01)

Prostate magnetic resonance imaging and the value of experience: An intrareader variability study
by: Thomas Whish-Wilson, et al.
Published: (2023-10-01)

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer
by: Jesse D Le, et al.
Published: (2014-08-01)

Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice
by: Kyung Tak Oh, et al.
Published: (2020-01-01)

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
by: Chang Wook Jeong, et al.
Published: (2014-12-01)

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
by: Marinus J. Hagens, et al.
Published: (2022-06-01)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
by: Mads Sandahl, et al.
Published: (2022-07-01)

Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer
by: Biagio Barone, et al.
Published: (2023-06-01)

Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies
by: Francesco Giganti, et al.
Published: (2022-04-01)

PROSTATE BIOPSY UNDER MAGNETIC RESONANCE IMAGING GUIDANCE
by: V. I. Kuplevatskiy, et al.
Published: (2016-05-01)

Transperineal Prostate Biopsy Targeted by Magnetic Resonance Imaging Cognitive Fusion
by: Petru Octavian Drăgoescu, et al.
Published: (2023-04-01)

‘Stealth’ Prostate Tumors
by: Vinayak G. Wagaskar, et al.
Published: (2023-07-01)

Impact of Ultrasonographic Findings on Cancer Detection Rate during Magnetic Resonance Image/ Ultrasonography Fusion-Targeted Prostate Biopsy
by: Jong Kil Nam, et al.
Published: (2023-07-01)

The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
by: Niranjan J. Sathianathen, et al.
Published: (2018-09-01)

Experience in the use of MRI-ultrasound fusion-targeted biopsy of the prostate for the diagnosis of prostate cancer
by: E. S. Nevirovich, et al.
Published: (2018-10-01)

Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece
by: Mario Lourenço, et al.
Published: (2020-01-01)

Transrectal ultrasound-guided prostate biopsy versus combined magnetic resonance imaging-ultrasound fusion and systematic biopsy for prostate cancer detection in routine clinical practice
by: Jae Heung Bae, et al.
Published: (2020-04-01)

MR-Guided Targeted Prostate Biopsy from Radiologists’ Perspective
by: So-Yeon Kim, et al.
Published: (2023-11-01)

Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists
by: Arnaldo Stanzione, et al.
Published: (2020-12-01)

False-positive magnetic resonance imaging prostate cancer correlates and clinical implications
by: Mostafa A Arafa, et al.
Published: (2023-01-01)

Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer
by: Sunao Shoji
Published: (2019-01-01)

The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate Cancer
by: Daniël L. van den Kroonenberg, et al.
Published: (2024-05-01)

Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization
by: Ja Yeon You, et al.
Published: (2015-09-01)

Impact of PI-RADS v2 on indication of prostate biopsy
by: George de Queiroz Rozas, et al.

Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer
by: Leonor Jane Paulino Pereira, et al.
Published: (2022-12-01)

Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Prostate Biopsy: Diagnostic Accuracy from a Single Center Retrospective Study
by: Andrea Fulco, et al.
Published: (2021-09-01)

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
by: Daiki Kato, et al.
Published: (2021-03-01)

Selecting patients for magnetic resonance imaging cognitive versus ultrasound fusion biopsy of the prostate: A within‐patient comparison
by: Mitch Hayes, et al.
Published: (2022-11-01)

Prostate cancer diagnosis as part of high-tech advanced outpatient medical care
by: A. R. Gevorkyan, et al.
Published: (2023-04-01)

FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY
by: A. A. Keln, et al.
Published: (2018-01-01)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
by: M Klingebiel, et al.
Published: (2022-12-01)